Inclusion Criteria  The participant is willing and able to provide signed informed consent. The participant is able and willing to perform study-related assessments. The participant is ≥18 years of age  The participant has one of the following diagnoses:  histologically confirmed inclusion body myositis (IBM), or genetically confirmed late-onset Pompe disease (LOPD), or genetically confirmed spinal muscular atrophy type 3 (SMA3), or genetically confirmed myotonic dystrophy type 1, or genetically confirmed myotonic dystrophy type 2, or genetically confirmed facio-scapulo-humeral muscle dystrophy (FSHD).  Exclusion Criteria  The participant is participating in another clinical study or using an investigational treatment. The participant, in the opinion of the Investigator, is unable to adhere to the requirements of the study. The participant has currently a severe depression, assessed by the Beck depression inventory fast screen (BDI-FS) with a score ≥ 4